{"version":3,"sources":["webpack:///path---before-13-ma-miso-only-regimen-a85fa43cf9e0895dc6a4.js","webpack:///./.cache/json/before-13-ma-miso-only-regimen.json"],"names":["webpackJsonp","420","module","exports","data","wordpressPage","title","content","fields","path","acf","last_reviewed","landing_page","parent","wordpress_parent","grandparent","site","id","siteMetadata","pathContext"],"mappings":"AAAAA,cAAc,iBAERC,IACA,SAAUC,EAAQC,GCHxBD,EAAAC,SAAkBC,MAAQC,eAAiBC,MAAA,wCAAAC,QAAA,2hNAA85MC,QAAiMC,KAAA,kCAAwCC,KAAQC,cAAA,WAAAC,cAAA,IAAiDC,QAAWP,MAAA,mBAAAE,QAAqCC,KAAA,gBAAsBK,iBAAA,KAAwBC,aAAgBT,MAAA,yDAAAE,QAA2EC,KAAA,cAAoBO,MAASC,GAAA,OAAAC,cAA4BZ,MAAA,2BAAkCa,aAAgBF,GAAA,uCAAAX,MAAA,wCAAAC,QAAA,2hNAA08MI,cAAA,WAAAE,OAAA,IAAAE,YAAA","file":"path---before-13-ma-miso-only-regimen-a85fa43cf9e0895dc6a4.js","sourcesContent":["webpackJsonp([40584643374581],{\n\n/***/ 420:\n/***/ (function(module, exports) {\n\n\tmodule.exports = {\"data\":{\"wordpressPage\":{\"title\":\"Misoprostol only: Recommended regimen\",\"content\":\"<h2>Recommended regimen before 13 weeks gestation:</h2>\\n<ul>\\n<li>Misoprostol 800mcg vaginally or sublingually every three hours until expulsion.</li>\\n</ul>\\n<h3>Strength of recommendation:  Strong</h3>\\n<h3></h3>\\n<h3>Quality of evidence:</h3>\\n<ul>\\n<li>Up to nine weeks gestation: Moderate</li>\\n<li>9-13 weeks gestation: Low</li>\\n</ul>\\n<p>Success of misoprostol-only medical abortion</p>\\n<p>The success rate of medical abortion with misoprostol only is around 85% (von Hertzen et al., 2007) and should be considered only when mifepristone is not available. In general, misoprostol-only regimens have higher rates of success at gestational ages less than 7 weeks (von Hertzen et al., 2007; Zikopoulos et al., 2002), with higher numbers of doses (Carbonell, Varela, Velazco, Tanda, &amp; Sanchez, 1999) and with a longer time before provider follow-up to confirm abortion success (Bugalho, Mocumbi, Faundes, &amp; David, 2000). However, women’s satisfaction decreases the longer the abortion process lasts (Ngai, Tang, Chan, &amp; Ho, 2000).</p>\\n<p>Misoprostol-only abortion up to 9 weeks</p>\\n<p>The only multicenter randomized controlled trial to compare different misoprostol-only dosing intervals showed that complete abortion rates are equivalent when misoprostol is given vaginally every 3-12 hours or sublingually every three hours for three doses. Sublingual dosing had a higher incidence of side effects than vaginal dosing (von Hertzen et al., 2007).</p>\\n<p>Misoprostol-only abortion between 9-13 weeks</p>\\n<p>There is scant evidence upon which to recommend an appropriate misoprostol-only regimen between 9-13 weeks. Findings from comparative trials indicate that vaginal and sublingual dosing have similar efficacy and are superior to oral dosing (Ganguly et al., 2010; Van Bogaert &amp; Misra, 2010). Several small cohort studies confirm the effectiveness of the both the vaginal and sublingual routes, and also confirm increased success when multiple doses of misoprostol are used (Carbonell Esteve et al., 1998; Carbonell et al., 1999; Carbonell et al., 2001; Grapsas et al., 2008; Tang, Miao, Lee, &amp; Ho, 2002). There is strong evidence in randomized controlled trials of misoprostol-only regimens that support using a vaginal dosing interval of every three hours for gestations over 13 weeks (von Hertzen et al., 2009). Extrapolating from the evidence supporting repeat doses of sublingual or vaginal misoprostol at gestations both below nine and above 13 weeks, the evidence-based regimen recommended for gestations below nine weeks may be used for gestations between 9-13 weeks.</p>\\n<p>Young women</p>\\n<p>Safety and efficacy of misoprostol-only abortion has been demonstrated in adolescents with pregnancies up to nine weeks gestation (Velazco et al., 2000) and between 9-12 weeks gestation (Carbonell et al., 2001). Success rates of misoprostol-only abortion in young women are similar to those seen in studies of older women.</p>\\n<h3>References</h3>\\n<p>Bugalho, A., Mocumbi, S., Faundes, A., &amp; David, E. (2000). Termination of pregnancies of &lt;6 weeks gestation with a single dose of 800 microg of vaginal misoprostol. <em>Contraception</em>, <em>61</em>(1), 47-50.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell Esteve, J. L., Varela, L., Velazco, A., Cabezas, E., Tanda, R., &amp; Sanchez, C. (1998). Vaginal misoprostol for late first trimester abortion. <em>Contraception</em>, <em>57</em>(5), 329-333.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Varela, L., Velazco, A., Tanda, R., &amp; Sanchez, C. (1999). Vaginal misoprostol for abortion at 10-13 weeks&#8217; gestation. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>4</em>(1), 35-40.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Velazco, A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., &amp; Mari, J. (2001). Misoprostol for abortion at 9-12 weeks&#8217; gestation in adolescents. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>6</em>(1), 39-45.</p>\\n<p>&nbsp;</p>\\n<p>Ganguly, R. P., Saha, S. P., Mukhopadhyay, S., Bhattacharjee, N., Bhattacharyya, S. K., &amp; Patra, K. K. (2010). A comparative study on sublingual versus oral and vaginal administration of misoprostol for later first and early second trimester abortion. <em>Journal of the Indian Medical Association, 108</em>(5), 283-286.</p>\\n<p>&nbsp;</p>\\n<p>Grapsas, X., Liberis, V., Vassaras, G., Tsikouras, P., Vlachos, G., &amp; Galazios, G. (2008). Misoprostol and first trimester pregnancy termination. <em>Clinical and Experimental Obstetrics and Gynecology</em>, <em>35</em>(1), 32-34.</p>\\n<p>Ngai, S. W., Tang, O. S., Chan, Y. M., &amp; Ho, P. C. (2000). Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>15</em>(5), 1159-1162.</p>\\n<p>&nbsp;</p>\\n<p>Tang O. S., Miao, B. Y., Lee, S. W. H., &amp; Ho, P. C. (2002). Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>17</em>(3), 654-658.</p>\\n<p>&nbsp;</p>\\n<p>Velazco A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., Chami, S., … Carbonell, J. L. (2000). Misoprostol for abortion up to 9 weeks&#8217; gestation in adolescents. <em>European Journal of Contraception and Reproductive Health Care</em>, <em>5</em>(4), 227-233.</p>\\n<p>&nbsp;</p>\\n<p>Van Bogaert, L. J., &amp; Misra, A. (2010). Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters. <em>International Journal of Gynecology &amp; Obstetrics, 109</em>(3), 213-215.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Huong, N. T., Arustamyan, K., Cabezas, E., Gomez, M., &amp; Peregoudov, A. (2007). Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: A randomised controlled equivalence trial. <em>The</em> <em>Lancet</em>, <em>369</em>(9577), 1938-1946.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Wojdyla, D., Nguyen, T. M., Marions, L., Okoev, G., &amp; Peregoudov, A. (2009). Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial. <em>Human Reproduction</em>, <em>24</em>(1), 106-112.</p>\\n<p>Zikopoulos, K. A., Papanikolaou, E. G., Kalantaridou, S. N., Tsanadis, G. D., Plachouras, N. I., Dalkalitsis, N. A., &amp; Paraskevaidis, E. A. (2002). Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. <em>Human Reproduction</em>, <em>17</em>(12), 3079-3083.</p>\\n\",\"fields\":{\"path\":\"before-13/ma/miso-only-regimen\"},\"acf\":{\"last_reviewed\":\"20180115\",\"landing_page\":false}},\"parent\":{\"title\":\"Medical abortion\",\"fields\":{\"path\":\"before-13/ma\"},\"wordpress_parent\":163},\"grandparent\":{\"title\":\"Recommendations for abortion before 13 weeks gestation\",\"fields\":{\"path\":\"before-13\"}},\"site\":{\"id\":\"Site\",\"siteMetadata\":{\"title\":\"Ipas Clinical Updates\"}}},\"pathContext\":{\"id\":\"c60b569b-dbd8-57f4-aba8-c5f462928139\",\"title\":\"Misoprostol only: Recommended regimen\",\"content\":\"<h2>Recommended regimen before 13 weeks gestation:</h2>\\n<ul>\\n<li>Misoprostol 800mcg vaginally or sublingually every three hours until expulsion.</li>\\n</ul>\\n<h3>Strength of recommendation:  Strong</h3>\\n<h3></h3>\\n<h3>Quality of evidence:</h3>\\n<ul>\\n<li>Up to nine weeks gestation: Moderate</li>\\n<li>9-13 weeks gestation: Low</li>\\n</ul>\\n<p>Success of misoprostol-only medical abortion</p>\\n<p>The success rate of medical abortion with misoprostol only is around 85% (von Hertzen et al., 2007) and should be considered only when mifepristone is not available. In general, misoprostol-only regimens have higher rates of success at gestational ages less than 7 weeks (von Hertzen et al., 2007; Zikopoulos et al., 2002), with higher numbers of doses (Carbonell, Varela, Velazco, Tanda, &amp; Sanchez, 1999) and with a longer time before provider follow-up to confirm abortion success (Bugalho, Mocumbi, Faundes, &amp; David, 2000). However, women’s satisfaction decreases the longer the abortion process lasts (Ngai, Tang, Chan, &amp; Ho, 2000).</p>\\n<p>Misoprostol-only abortion up to 9 weeks</p>\\n<p>The only multicenter randomized controlled trial to compare different misoprostol-only dosing intervals showed that complete abortion rates are equivalent when misoprostol is given vaginally every 3-12 hours or sublingually every three hours for three doses. Sublingual dosing had a higher incidence of side effects than vaginal dosing (von Hertzen et al., 2007).</p>\\n<p>Misoprostol-only abortion between 9-13 weeks</p>\\n<p>There is scant evidence upon which to recommend an appropriate misoprostol-only regimen between 9-13 weeks. Findings from comparative trials indicate that vaginal and sublingual dosing have similar efficacy and are superior to oral dosing (Ganguly et al., 2010; Van Bogaert &amp; Misra, 2010). Several small cohort studies confirm the effectiveness of the both the vaginal and sublingual routes, and also confirm increased success when multiple doses of misoprostol are used (Carbonell Esteve et al., 1998; Carbonell et al., 1999; Carbonell et al., 2001; Grapsas et al., 2008; Tang, Miao, Lee, &amp; Ho, 2002). There is strong evidence in randomized controlled trials of misoprostol-only regimens that support using a vaginal dosing interval of every three hours for gestations over 13 weeks (von Hertzen et al., 2009). Extrapolating from the evidence supporting repeat doses of sublingual or vaginal misoprostol at gestations both below nine and above 13 weeks, the evidence-based regimen recommended for gestations below nine weeks may be used for gestations between 9-13 weeks.</p>\\n<p>Young women</p>\\n<p>Safety and efficacy of misoprostol-only abortion has been demonstrated in adolescents with pregnancies up to nine weeks gestation (Velazco et al., 2000) and between 9-12 weeks gestation (Carbonell et al., 2001). Success rates of misoprostol-only abortion in young women are similar to those seen in studies of older women.</p>\\n<h3>References</h3>\\n<p>Bugalho, A., Mocumbi, S., Faundes, A., &amp; David, E. (2000). Termination of pregnancies of &lt;6 weeks gestation with a single dose of 800 microg of vaginal misoprostol. <em>Contraception</em>, <em>61</em>(1), 47-50.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell Esteve, J. L., Varela, L., Velazco, A., Cabezas, E., Tanda, R., &amp; Sanchez, C. (1998). Vaginal misoprostol for late first trimester abortion. <em>Contraception</em>, <em>57</em>(5), 329-333.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Varela, L., Velazco, A., Tanda, R., &amp; Sanchez, C. (1999). Vaginal misoprostol for abortion at 10-13 weeks&#8217; gestation. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>4</em>(1), 35-40.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Velazco, A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., &amp; Mari, J. (2001). Misoprostol for abortion at 9-12 weeks&#8217; gestation in adolescents. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>6</em>(1), 39-45.</p>\\n<p>&nbsp;</p>\\n<p>Ganguly, R. P., Saha, S. P., Mukhopadhyay, S., Bhattacharjee, N., Bhattacharyya, S. K., &amp; Patra, K. K. (2010). A comparative study on sublingual versus oral and vaginal administration of misoprostol for later first and early second trimester abortion. <em>Journal of the Indian Medical Association, 108</em>(5), 283-286.</p>\\n<p>&nbsp;</p>\\n<p>Grapsas, X., Liberis, V., Vassaras, G., Tsikouras, P., Vlachos, G., &amp; Galazios, G. (2008). Misoprostol and first trimester pregnancy termination. <em>Clinical and Experimental Obstetrics and Gynecology</em>, <em>35</em>(1), 32-34.</p>\\n<p>Ngai, S. W., Tang, O. S., Chan, Y. M., &amp; Ho, P. C. (2000). Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>15</em>(5), 1159-1162.</p>\\n<p>&nbsp;</p>\\n<p>Tang O. S., Miao, B. Y., Lee, S. W. H., &amp; Ho, P. C. (2002). Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>17</em>(3), 654-658.</p>\\n<p>&nbsp;</p>\\n<p>Velazco A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., Chami, S., … Carbonell, J. L. (2000). Misoprostol for abortion up to 9 weeks&#8217; gestation in adolescents. <em>European Journal of Contraception and Reproductive Health Care</em>, <em>5</em>(4), 227-233.</p>\\n<p>&nbsp;</p>\\n<p>Van Bogaert, L. J., &amp; Misra, A. (2010). Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters. <em>International Journal of Gynecology &amp; Obstetrics, 109</em>(3), 213-215.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Huong, N. T., Arustamyan, K., Cabezas, E., Gomez, M., &amp; Peregoudov, A. (2007). Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: A randomised controlled equivalence trial. <em>The</em> <em>Lancet</em>, <em>369</em>(9577), 1938-1946.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Wojdyla, D., Nguyen, T. M., Marions, L., Okoev, G., &amp; Peregoudov, A. (2009). Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial. <em>Human Reproduction</em>, <em>24</em>(1), 106-112.</p>\\n<p>Zikopoulos, K. A., Papanikolaou, E. G., Kalantaridou, S. N., Tsanadis, G. D., Plachouras, N. I., Dalkalitsis, N. A., &amp; Paraskevaidis, E. A. (2002). Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. <em>Human Reproduction</em>, <em>17</em>(12), 3079-3083.</p>\\n\",\"last_reviewed\":\"20180115\",\"parent\":185,\"grandparent\":163}}\n\n/***/ })\n\n});\n\n\n// WEBPACK FOOTER //\n// path---before-13-ma-miso-only-regimen-a85fa43cf9e0895dc6a4.js","module.exports = {\"data\":{\"wordpressPage\":{\"title\":\"Misoprostol only: Recommended regimen\",\"content\":\"<h2>Recommended regimen before 13 weeks gestation:</h2>\\n<ul>\\n<li>Misoprostol 800mcg vaginally or sublingually every three hours until expulsion.</li>\\n</ul>\\n<h3>Strength of recommendation:  Strong</h3>\\n<h3></h3>\\n<h3>Quality of evidence:</h3>\\n<ul>\\n<li>Up to nine weeks gestation: Moderate</li>\\n<li>9-13 weeks gestation: Low</li>\\n</ul>\\n<p>Success of misoprostol-only medical abortion</p>\\n<p>The success rate of medical abortion with misoprostol only is around 85% (von Hertzen et al., 2007) and should be considered only when mifepristone is not available. In general, misoprostol-only regimens have higher rates of success at gestational ages less than 7 weeks (von Hertzen et al., 2007; Zikopoulos et al., 2002), with higher numbers of doses (Carbonell, Varela, Velazco, Tanda, &amp; Sanchez, 1999) and with a longer time before provider follow-up to confirm abortion success (Bugalho, Mocumbi, Faundes, &amp; David, 2000). However, women’s satisfaction decreases the longer the abortion process lasts (Ngai, Tang, Chan, &amp; Ho, 2000).</p>\\n<p>Misoprostol-only abortion up to 9 weeks</p>\\n<p>The only multicenter randomized controlled trial to compare different misoprostol-only dosing intervals showed that complete abortion rates are equivalent when misoprostol is given vaginally every 3-12 hours or sublingually every three hours for three doses. Sublingual dosing had a higher incidence of side effects than vaginal dosing (von Hertzen et al., 2007).</p>\\n<p>Misoprostol-only abortion between 9-13 weeks</p>\\n<p>There is scant evidence upon which to recommend an appropriate misoprostol-only regimen between 9-13 weeks. Findings from comparative trials indicate that vaginal and sublingual dosing have similar efficacy and are superior to oral dosing (Ganguly et al., 2010; Van Bogaert &amp; Misra, 2010). Several small cohort studies confirm the effectiveness of the both the vaginal and sublingual routes, and also confirm increased success when multiple doses of misoprostol are used (Carbonell Esteve et al., 1998; Carbonell et al., 1999; Carbonell et al., 2001; Grapsas et al., 2008; Tang, Miao, Lee, &amp; Ho, 2002). There is strong evidence in randomized controlled trials of misoprostol-only regimens that support using a vaginal dosing interval of every three hours for gestations over 13 weeks (von Hertzen et al., 2009). Extrapolating from the evidence supporting repeat doses of sublingual or vaginal misoprostol at gestations both below nine and above 13 weeks, the evidence-based regimen recommended for gestations below nine weeks may be used for gestations between 9-13 weeks.</p>\\n<p>Young women</p>\\n<p>Safety and efficacy of misoprostol-only abortion has been demonstrated in adolescents with pregnancies up to nine weeks gestation (Velazco et al., 2000) and between 9-12 weeks gestation (Carbonell et al., 2001). Success rates of misoprostol-only abortion in young women are similar to those seen in studies of older women.</p>\\n<h3>References</h3>\\n<p>Bugalho, A., Mocumbi, S., Faundes, A., &amp; David, E. (2000). Termination of pregnancies of &lt;6 weeks gestation with a single dose of 800 microg of vaginal misoprostol. <em>Contraception</em>, <em>61</em>(1), 47-50.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell Esteve, J. L., Varela, L., Velazco, A., Cabezas, E., Tanda, R., &amp; Sanchez, C. (1998). Vaginal misoprostol for late first trimester abortion. <em>Contraception</em>, <em>57</em>(5), 329-333.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Varela, L., Velazco, A., Tanda, R., &amp; Sanchez, C. (1999). Vaginal misoprostol for abortion at 10-13 weeks&#8217; gestation. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>4</em>(1), 35-40.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Velazco, A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., &amp; Mari, J. (2001). Misoprostol for abortion at 9-12 weeks&#8217; gestation in adolescents. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>6</em>(1), 39-45.</p>\\n<p>&nbsp;</p>\\n<p>Ganguly, R. P., Saha, S. P., Mukhopadhyay, S., Bhattacharjee, N., Bhattacharyya, S. K., &amp; Patra, K. K. (2010). A comparative study on sublingual versus oral and vaginal administration of misoprostol for later first and early second trimester abortion. <em>Journal of the Indian Medical Association, 108</em>(5), 283-286.</p>\\n<p>&nbsp;</p>\\n<p>Grapsas, X., Liberis, V., Vassaras, G., Tsikouras, P., Vlachos, G., &amp; Galazios, G. (2008). Misoprostol and first trimester pregnancy termination. <em>Clinical and Experimental Obstetrics and Gynecology</em>, <em>35</em>(1), 32-34.</p>\\n<p>Ngai, S. W., Tang, O. S., Chan, Y. M., &amp; Ho, P. C. (2000). Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>15</em>(5), 1159-1162.</p>\\n<p>&nbsp;</p>\\n<p>Tang O. S., Miao, B. Y., Lee, S. W. H., &amp; Ho, P. C. (2002). Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>17</em>(3), 654-658.</p>\\n<p>&nbsp;</p>\\n<p>Velazco A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., Chami, S., … Carbonell, J. L. (2000). Misoprostol for abortion up to 9 weeks&#8217; gestation in adolescents. <em>European Journal of Contraception and Reproductive Health Care</em>, <em>5</em>(4), 227-233.</p>\\n<p>&nbsp;</p>\\n<p>Van Bogaert, L. J., &amp; Misra, A. (2010). Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters. <em>International Journal of Gynecology &amp; Obstetrics, 109</em>(3), 213-215.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Huong, N. T., Arustamyan, K., Cabezas, E., Gomez, M., &amp; Peregoudov, A. (2007). Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: A randomised controlled equivalence trial. <em>The</em> <em>Lancet</em>, <em>369</em>(9577), 1938-1946.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Wojdyla, D., Nguyen, T. M., Marions, L., Okoev, G., &amp; Peregoudov, A. (2009). Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial. <em>Human Reproduction</em>, <em>24</em>(1), 106-112.</p>\\n<p>Zikopoulos, K. A., Papanikolaou, E. G., Kalantaridou, S. N., Tsanadis, G. D., Plachouras, N. I., Dalkalitsis, N. A., &amp; Paraskevaidis, E. A. (2002). Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. <em>Human Reproduction</em>, <em>17</em>(12), 3079-3083.</p>\\n\",\"fields\":{\"path\":\"before-13/ma/miso-only-regimen\"},\"acf\":{\"last_reviewed\":\"20180115\",\"landing_page\":false}},\"parent\":{\"title\":\"Medical abortion\",\"fields\":{\"path\":\"before-13/ma\"},\"wordpress_parent\":163},\"grandparent\":{\"title\":\"Recommendations for abortion before 13 weeks gestation\",\"fields\":{\"path\":\"before-13\"}},\"site\":{\"id\":\"Site\",\"siteMetadata\":{\"title\":\"Ipas Clinical Updates\"}}},\"pathContext\":{\"id\":\"c60b569b-dbd8-57f4-aba8-c5f462928139\",\"title\":\"Misoprostol only: Recommended regimen\",\"content\":\"<h2>Recommended regimen before 13 weeks gestation:</h2>\\n<ul>\\n<li>Misoprostol 800mcg vaginally or sublingually every three hours until expulsion.</li>\\n</ul>\\n<h3>Strength of recommendation:  Strong</h3>\\n<h3></h3>\\n<h3>Quality of evidence:</h3>\\n<ul>\\n<li>Up to nine weeks gestation: Moderate</li>\\n<li>9-13 weeks gestation: Low</li>\\n</ul>\\n<p>Success of misoprostol-only medical abortion</p>\\n<p>The success rate of medical abortion with misoprostol only is around 85% (von Hertzen et al., 2007) and should be considered only when mifepristone is not available. In general, misoprostol-only regimens have higher rates of success at gestational ages less than 7 weeks (von Hertzen et al., 2007; Zikopoulos et al., 2002), with higher numbers of doses (Carbonell, Varela, Velazco, Tanda, &amp; Sanchez, 1999) and with a longer time before provider follow-up to confirm abortion success (Bugalho, Mocumbi, Faundes, &amp; David, 2000). However, women’s satisfaction decreases the longer the abortion process lasts (Ngai, Tang, Chan, &amp; Ho, 2000).</p>\\n<p>Misoprostol-only abortion up to 9 weeks</p>\\n<p>The only multicenter randomized controlled trial to compare different misoprostol-only dosing intervals showed that complete abortion rates are equivalent when misoprostol is given vaginally every 3-12 hours or sublingually every three hours for three doses. Sublingual dosing had a higher incidence of side effects than vaginal dosing (von Hertzen et al., 2007).</p>\\n<p>Misoprostol-only abortion between 9-13 weeks</p>\\n<p>There is scant evidence upon which to recommend an appropriate misoprostol-only regimen between 9-13 weeks. Findings from comparative trials indicate that vaginal and sublingual dosing have similar efficacy and are superior to oral dosing (Ganguly et al., 2010; Van Bogaert &amp; Misra, 2010). Several small cohort studies confirm the effectiveness of the both the vaginal and sublingual routes, and also confirm increased success when multiple doses of misoprostol are used (Carbonell Esteve et al., 1998; Carbonell et al., 1999; Carbonell et al., 2001; Grapsas et al., 2008; Tang, Miao, Lee, &amp; Ho, 2002). There is strong evidence in randomized controlled trials of misoprostol-only regimens that support using a vaginal dosing interval of every three hours for gestations over 13 weeks (von Hertzen et al., 2009). Extrapolating from the evidence supporting repeat doses of sublingual or vaginal misoprostol at gestations both below nine and above 13 weeks, the evidence-based regimen recommended for gestations below nine weeks may be used for gestations between 9-13 weeks.</p>\\n<p>Young women</p>\\n<p>Safety and efficacy of misoprostol-only abortion has been demonstrated in adolescents with pregnancies up to nine weeks gestation (Velazco et al., 2000) and between 9-12 weeks gestation (Carbonell et al., 2001). Success rates of misoprostol-only abortion in young women are similar to those seen in studies of older women.</p>\\n<h3>References</h3>\\n<p>Bugalho, A., Mocumbi, S., Faundes, A., &amp; David, E. (2000). Termination of pregnancies of &lt;6 weeks gestation with a single dose of 800 microg of vaginal misoprostol. <em>Contraception</em>, <em>61</em>(1), 47-50.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell Esteve, J. L., Varela, L., Velazco, A., Cabezas, E., Tanda, R., &amp; Sanchez, C. (1998). Vaginal misoprostol for late first trimester abortion. <em>Contraception</em>, <em>57</em>(5), 329-333.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Varela, L., Velazco, A., Tanda, R., &amp; Sanchez, C. (1999). Vaginal misoprostol for abortion at 10-13 weeks&#8217; gestation. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>4</em>(1), 35-40.</p>\\n<p>&nbsp;</p>\\n<p>Carbonell, J. L., Velazco, A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., &amp; Mari, J. (2001). Misoprostol for abortion at 9-12 weeks&#8217; gestation in adolescents. <em>The European Journal of Contraception and Reproductive Health Care</em>, <em>6</em>(1), 39-45.</p>\\n<p>&nbsp;</p>\\n<p>Ganguly, R. P., Saha, S. P., Mukhopadhyay, S., Bhattacharjee, N., Bhattacharyya, S. K., &amp; Patra, K. K. (2010). A comparative study on sublingual versus oral and vaginal administration of misoprostol for later first and early second trimester abortion. <em>Journal of the Indian Medical Association, 108</em>(5), 283-286.</p>\\n<p>&nbsp;</p>\\n<p>Grapsas, X., Liberis, V., Vassaras, G., Tsikouras, P., Vlachos, G., &amp; Galazios, G. (2008). Misoprostol and first trimester pregnancy termination. <em>Clinical and Experimental Obstetrics and Gynecology</em>, <em>35</em>(1), 32-34.</p>\\n<p>Ngai, S. W., Tang, O. S., Chan, Y. M., &amp; Ho, P. C. (2000). Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>15</em>(5), 1159-1162.</p>\\n<p>&nbsp;</p>\\n<p>Tang O. S., Miao, B. Y., Lee, S. W. H., &amp; Ho, P. C. (2002). Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability. <em>Human Reproduction</em>, <em>17</em>(3), 654-658.</p>\\n<p>&nbsp;</p>\\n<p>Velazco A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., Chami, S., … Carbonell, J. L. (2000). Misoprostol for abortion up to 9 weeks&#8217; gestation in adolescents. <em>European Journal of Contraception and Reproductive Health Care</em>, <em>5</em>(4), 227-233.</p>\\n<p>&nbsp;</p>\\n<p>Van Bogaert, L. J., &amp; Misra, A. (2010). Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters. <em>International Journal of Gynecology &amp; Obstetrics, 109</em>(3), 213-215.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Huong, N. T., Arustamyan, K., Cabezas, E., Gomez, M., &amp; Peregoudov, A. (2007). Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: A randomised controlled equivalence trial. <em>The</em> <em>Lancet</em>, <em>369</em>(9577), 1938-1946.</p>\\n<p>&nbsp;</p>\\n<p>von Hertzen, H., Piaggio, G., Wojdyla, D., Nguyen, T. M., Marions, L., Okoev, G., &amp; Peregoudov, A. (2009). Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial. <em>Human Reproduction</em>, <em>24</em>(1), 106-112.</p>\\n<p>Zikopoulos, K. A., Papanikolaou, E. G., Kalantaridou, S. N., Tsanadis, G. D., Plachouras, N. I., Dalkalitsis, N. A., &amp; Paraskevaidis, E. A. (2002). Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. <em>Human Reproduction</em>, <em>17</em>(12), 3079-3083.</p>\\n\",\"last_reviewed\":\"20180115\",\"parent\":185,\"grandparent\":163}}\n\n\n//////////////////\n// WEBPACK FOOTER\n// ./~/json-loader!./.cache/json/before-13-ma-miso-only-regimen.json\n// module id = 420\n// module chunks = 40584643374581"],"sourceRoot":""}